Prof Joe Viljoen, from the Faculty of Health Sciences at NWU, examined how self-emulsifying drug delivery systems can improve ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Research keeps you on the forefront and provides opportunities for patients and staff. It’s the only way we’ll ever move ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

Staying Golden: Aging With HIV: The Way Forward A longtime HIV/AIDS researcher and clinician maps out potential ways to approach a curative strategy, and comments on the need for global resources ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Sabino Canyon Road. The award is well-deserved by Blades, who co-founded the Tucson HIV/AIDS Network (TIHAN) in 1994 and has been a champion of care for people impacted by HIV and AIDS ever since.